Comparative proteome analysis revealed up-regulation of transthyretin in rat brain under chronic clozapine treatment

Journal of Psychiatric Research

Volumn 41, Issue 1-2, 2007, Pages 63-68

  Chen, Mao Liang ^a   Chen, Chia Hsiang ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Antipsychotics; Gene expression; Proteomics; Schizophrenia; Transthyretin

Indexed keywords

CLOZAPINE; HALOPERIDOL; OLANZAPINE; PREALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN CELL; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HIPPOCAMPUS; MALE; MASS SPECTROMETRY; MOLECULAR DYNAMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; NUTRITIONAL ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEOMICS; QUANTITATIVE ANALYSIS; RAT; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WEIGHT GAIN; WESTERN BLOTTING;

EID: 33750695928     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2005.04.006     Document Type: Article

References (32)

1. Appella E., Arnott D., Sakaguchi K., and Wirth P.J. Proteome mapping by two-dimensional poly-acrylamide gel electrophoresis in combination with mass spectrometric protein sequence analysis. In: Jolles P., and Jornvall H. (Eds). Proteomics in functional genomics (2000), Birkhaeuser Verlag, Basel 1-27
2. Ashby Jr. C.R., and Wang R.Y. Pharmacological actions of the atypical antipsychotic drug clozapine: a review. Synapse 24 (1996) 349-394
3. Bai O., Chlan-Fourney J., Bowen R., Keegan D., and Li X.M. Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs. Journal of Neuroscience Research 71 (2003) 127-131
4. Blackstock W.P., and Weir M.P. Proteomics: quantitative and physical mapping of cellular proteins. Trends in Biotechnology 17 (1999) 121-127
5. Chlan-Fourney J., Ashe P., Nylen K., Juorio A.V., and Li X.M. Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration. Brain Ressearch 954 (2002) 11-20
6. de Urquiza A.M., Liu S., Sjoberg M., Zetterstrom R.H., Griffiths W., Sjovall J., and Perlmann T. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 290 (2000) 2140-2144
7. Eng J.K., McCormick A.L., and Yates III J.R. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. Journal of the American Society of Mass Spectrometry 5 (1994) 976-989
8. Fan Y.Y., Spencer T.E., Wang N., Moyer M.P., and Chapkin R.S. Chemopreventive n - 3 fatty acids activate RXRalpha in colonocytes. Carcinogenesis 24 (2003) 1541-1548
9. Gaetani S., Bellovino D., Apreda M., and Devirgilitis C. Hepatic synthesis, maturation and complex formation between retinal-binding protein and transthyretin. Clinical Chemistry and Laboratory Medicine 40 (2002) 1211-1220
10. Gemperle A.Y., Enz A., Pozza M.F., Luthi A., and Olpe H.R. Effects of clozapine, haloperidol and risperidone on neurotransmission and synaptic plasticity in prefrontal cortex and their accumulation in brain tissue: an in vitro study. Neuroscience 117 (2003) 681-695
11. Goodman A.B. Elevated risks for amyotrophic lateral sclerosis and blood disorders in Ashkenazi schizophrenic pedigrees suggest new candidate genes in schizophrenia. American Journal of Medical Genetics 54 (1994) 271-278
12. Goodman A.B. Chromosomal locations and modes of action of genes of the retinoid (vitamin A) system support their involvement in the etiology of schizophrenia. American Journal of Medical Genetics 60 (1995) 335-348
13. Goodman A.B. Is transthyretin (TTR) disrupted by a trinucleotide repeat expansion in a schizophrenia kindred?. American Journal of Medical Genetics 81 (1998) 347-348
14. Goodman A.B. Three independent lines of evidence suggest retinoids as causal to schizophrenia. Proceedings of the National Academy of Sciences USA 95 (1998) 7240-7244
15. Horrobin D.F. A new category of psychotropic drugs: neuroactive lipids as exemplified by ethyl eicosapentaenoate (E-E). Progress in Drug Research 59 (2002) 171-199
16. Hyman S.E., and Nestler E.J. Initiation and adaptation: a paradigm for understanding psychotropic drug action. American Journal of Psychiatry 153 (1996) 151-162
17. Konradi C., and Heckers S. Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia. Biological Psychiatry 50 (2001) 729-742
18. Linden A.M., Vaisanen J., Lakso M., Nawa H., Wong G., and Castren E. Expression of neurotrophins BDNF and NT-3 and their receptors in rat brain after administration of antipsychotic and psychotrophic agents. Journal of Molecular Neuroscience 14 (2000) 27-37
19. O'Farrell P.H. High resolution two-dimensional electrophoresis of proteins. Journal of Biological Chemistry 250 (1975) 4007-4021
20. Ozaki T. Comparative effects of dopamine D(1) and D(2) receptor antagonists on nerve growth factor protein induction. European Journal of Pharmacology 402 (2000) 39-44
21. Ozaki T., Mui K., and Yamagami S. Comparison of the effects of dopamine D1 and D2 receptor antagonists on nerve growth factor mRNA expression. European Journal of Pharmacology 369 (1999) 133-143
22. Palha J.A. Transthyretin as a thyroid hormone carrier: function revisited. Clinical Chemistry and Labtory Medicine 40 (2002) 1292-1300
23. Puskas L.G., Kitajka K., Nyakas C., Barcelo-Coblijn G., and Farkas T. Short-term administration of omega 3 fatty acids from fish oil results in increased transthyretin transcription in old rat hippocampus. Proceedings of the National Academy of Sciences USA 100 (2003) 1580-1585
24. Riisoen H. Reduced prealbumin (transthyretin) in CSF of severely demented patient with Alzheimer's disease. Acta Neurologica Scandinavica 78 (1998) 455-459
25. Schwarzman A.L., Gregori L., Vitek M.P., Lyubski S., Strittmatter W.J., Enghilde J.J., et al. Transthyretin sequesters amyloid beta protein and prevents amyloid formation. Proceedings of the National Academy of Sciences USA 91 (1994) 8368-8372
26. Serot J.M., Christmann D., Dubost T., and Couturier M. Cerebrospinal fluid transthyretin: aging and late-onset Alzheimer's disease. Journal of Neurology, Neurosurgery Psychiatry 63 (1997) 506-508
27. Soprano D.R., Herbert J., Soprano K.J., Schon E.A., and Goodman D.A. Demonstration of transthyretin mRNA in the brain and other extrahepatic tissues in the rat. Journal of Biological Chemistry 260 (1985) 11793-11798
28. Stein T.D., and Johnson J.A. Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. Journal of Neuroscience 22 (2002) 7380-7388
29. Tsay Y.G., Wang Y.H., Chiu C.M., Shen B.J., and Lee S.C. A strategy for identification and quantitation of phosphopeptides by liquid chromatography/tandem mass spectrometry. Analytical Biochemistry 287 (2000) 55-64
30. Van Tol H.H., Bunzow J.R., Guan H.C., Sunahara R.K., Seeman P., Niznik H.B., and Civelli O. Cloning of a human dopamine D4 receptor gene with high affinity for the antipsychotic clozapine. Nature 350 (1991) 614-619
31. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., and Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology 3 (2002) 0034.1-0034.11
32. Weickert T.W., Goldberg T.E., Marenco S., Bigrlow L.B., Egan M.F., and Weinberger D.R. Comparison of cognitive performances during a placebo period and an atypical antipsychotic treatment period in schizophrenia: critical examination of confounds. Neuropsychopharmacology 28 (2003) 1491-1500